Publications

506 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:
  1. Organisation chart 2025

    This document gives an overview of the members of the Executive Board (RvB), the management of the National Health Care Institute ...

    Publication | 22-04-2025

  2. Multi-year research agenda

    The multi-year research agenda of the National Health Care Institute provides direction on what we research. Our research ...

    Report | 30-01-2025

  3. Advice - reimburse lisocabtagene maraleucel (Breyanzi®) for the treatment of lymphoma

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse lisocabtagene ...

    Report | 16-12-2024

  4. Report - Cost-effectiveness: recommendations for surrogate endpoints

    The National Health Care Institute and similar government organisations in England, Canada, the United States, Colombia and ...

    Report | 01-11-2024

  5. Advice - reimburse atogepant (Aquipta®) for the treatment of migraine

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse atogepant (Aquipta®) ...

    Report | 23-10-2024

  6. Advice - do not reimburse olaparib (Lynparza®) in combination with abiraterone for the treatment of metastatic prostate cancer

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to not reimburse olaparib ...

    Report | 10-10-2024

  7. Advice - do not reimburse 9vHPV vaccine (Gardasil 9®) against cancer due to HPV virus for certain women

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) not to reimburse 9vHPV vaccine ...

    Report | 08-10-2024

  8. Taking care of good healthcare

    Video | 03-10-2024

  9. Advice - reimburse fluorouracil cream (Tolak®) for the treatment of the skin condition actinic keratosis

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse 5-fluorouracil 4% ...

    Report | 02-10-2024

  10. Advice - reimburse mometasone/olopatadine nasal spray (Ryaltris®) for the treatment of allergic rhinitis

    The National Health Care Institute has advised the minister of Health, Welfare and Sport to reimburse mometasone/olopatadine ...

    Report | 24-09-2024